Arrowhead Pharmaceuticals Inc (ARWR)

EBITDA Margin

-196.25%

Quarterly · Period ending:

ARWR logo

ARWR EBITDA Margin

Latest reported-196.25%
ARWR Quarterly EBITDA Margin (-33.33% → -196.25%)
High-resolution chart · PNG

ARWR ebitda margin history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Arrowhead Pharmaceuticals Inc EBITDA Margin — Quarterly
Period endingEBITDA Margin
-196.25%
-145.5863%
21.6511%
25.0324%
-534.7499%
73.214%
-5,929.36%
0%
0%
0%
-3,634.441%
-620.42%
-599.9937%
37.8773%
-57.9669%
-257.0705%
-214.2787%
30.9344%
-221.3929%
-162.9418%
-65.0912%
-80.1987%
-104.2388%
-633.3764%
-52.6373%
-88.6906%
-12.1983%
24.7626%
45.9034%
48.1568%
34.9796%
-88.3226%
-2,026.9432%
-2,135.0914%
-361.0618%
-104.3827%
-48.7183%
-54.9971%
-314.1974%
-60,482.2848%
-46,796.0665%
-46,767.8697%
-42,392.9623%
-55,712.6423%
-12,325.3721%
-66,704.4206%
-14,538.9382%
-45,512.0091%
-28,397.8194%
-24,723.9291%
-15,099.376%
-17,371.7463%
-10,577.6731%
-11,294.9097%
-2,742.1291%
-11,271.5634%
-13,313.6903%
-14,223.3888%
-14,961.996%
0%
0%
0%
-1,103.2002%
-1,218.2795%
0%
66.5292%
-1,341.2175%
-1,634.7823%
-77.4394%
-2,102.6111%
-1,181.2238%
18,855.7243%
-4,091.1978%
-928.4043%
-1,638.2685%
-1,964.528%
-2,111.2628%
0%
-38,253.3538%
-21,687.1575%
-1,743.7138%
-10,011.5913%
-1,538.4943%
-866.9186%
-1,531.409%
-1,958.3786%
-1,212.6821%
-896.0058%
-1,597.5699%
0%
0%
0%
-6,472.4638%
-3,173.3714%
-1,947.8011%
-1,477,758.427%
-16,244.8148%
-4,029.1892%
-1,901.4793%
-4,147.6389%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.